Host Cell Protein Lateral Flow Testing for On-Site Bioprocessing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for detecting host cell proteins (HCPs) in biopharmaceutical production are time-consuming and require laboratory-based analysis, limiting the ability to optimize manufacturing processes in real-time.
Innovation Solution
Utilization of lateral flow devices with polyclonal antibodies to detect HCPs on-site within 25 minutes, allowing for rapid and accurate assessment of HCP concentrations using nitrocellulose membranes and gold particle conjugates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional methods (ELISA, Western blot, LC-MS) are used to detect HCPs, then measurement precision is improved, but loss of time increases
Solution Approach 1:
The patent extracts the detection function from complex laboratory-based methods (ELISA, Western blot, LC-MS) and implements it in a simplified lateral flow device format. This extraction allows the core detection capability to be removed from the time-consuming laboratory environment and performed rapidly at the production site, reducing testing time from over an hour to under 30 minutes while preserving HCP detection accuracy through the use of polyclonal antibodies and gold particle conjugates.
2Measurement precision
If conventional laboratory-based testing is performed, then measurement precision is improved, but device complexity increases
Solution Approach 1:
The patent employs disposable lateral flow test strips that integrate the detection function into a single-use, portable device. These strips contain polyclonal antibodies conjugated to gold particles and a nitrocellulose membrane with test and control lines. The disposable nature eliminates the need for complex, expensive laboratory equipment while maintaining detection precision through the carefully designed immunological reaction system embedded in the strip.
3Measurement precision
If conventional testing methods are used, then measurement precision is improved, but ease of operation deteriorates
Solution Approach 1:
The lateral flow device is designed to perform the detection function autonomously without requiring complex laboratory procedures. The device self-assembles the detection components (antibody-gold particle conjugates, nitrocellulose membrane with capture antibodies) and automatically processes the sample through capillary action. The polyclonal antibodies specifically bind to HCPs in the sample, and the result is visualized through colorimetric changes at the test and control lines, eliminating the need for skilled laboratory personnel and complex operational steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables timely detection of HCPs during biopharmaceutical production, facilitating immediate process adjustments and ensuring compliance with regulatory standards by providing rapid, qualitative or quantitative results.
Implementation Method 1
The robustness of lateral flow testing devices allows for more active testing of products at the source
Implementation Method 2
a region of polyclonal antibodies that specifically bind to host cell proteins from a host cell line or a host cell culture
Data Source
AI summary
Time sensitive biopharmaceutical processing updates can be implemented using lateral flow devices to test on-site during manufacturing. Lateral flow testing for an analyte such as, for example, impurities (e.g., host cell proteins), during manufacturing of a biopharmaceutical drug product is completed within twenty-five minutes of collecting a sample from the manufacturing line. That is, all sample preparation, such as adding reagent or diluting the sample, contacting the prepared sample to a lateral flow device, and detecting presence or absence of the analyte is completed within twenty-five minutes (e.g., 20 minutes, 18 minutes, 15 minutes) from collection such that processing adjustments during manufacturing can be implemented.